Fidia S.p.A. (BIT:FDA)
0.0118
0.00 (0.00%)
Feb 21, 2025, 5:35 PM CET
Fidia Revenue
Fidia had revenue of 9.42M EUR in the half year ending June 30, 2024, a decrease of -0.16%. This brings the company's revenue in the last twelve months to 29.17M, up 20.45% year-over-year. In the year 2023, Fidia had annual revenue of 28.74M with 16.52% growth.
Revenue (ttm)
29.17M
Revenue Growth
+20.45%
P/S Ratio
0.01
Revenue / Employee
170.57K
Employees
193
Market Cap
366.89K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 28.74M | 4.07M | 16.52% |
Dec 31, 2022 | 24.66M | 485.00K | 2.01% |
Dec 31, 2021 | 24.18M | 2.52M | 11.65% |
Dec 31, 2020 | 21.65M | -24.55M | -53.13% |
Dec 31, 2019 | 46.20M | -12.65M | -21.50% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Leonardo S.p.a. | 17.10B |
Prysmian | 15.93B |
Poste Italiane | 13.25B |
Iveco Group | 15.29B |
Interpump Group | 2.08B |
Maire | 5.28B |
Webuild | 10.01B |
Fincantieri | 7.65B |
Fidia News
- 9 hours ago - FDA said to be reversing terminations made last week - Seeking Alpha
- 11 hours ago - Alvotech (ALVO) Announces FDA Approval and U.S. Launch of SELARSDI⢠- GuruFocus
- 17 hours ago - Dying to be thin? The FDA must regulate counterfeit weight loss drugs, says AG Bonta | Opinion - Yahoo
- 1 day ago - Ozempic and Wegovy officially moved off FDA's drug shortage list - The Hill
- 1 day ago - HIMS Stock Declines Amid FDA Announcement - GuruFocus
- 1 day ago - Dr. Scott Gottlieb says he's not too concerned on reports of a new coronavirus in China - CNBC
- 1 day ago - Hims & Hers Stock Drops as FDA Says Ozempic and Wegovy No Longer in Short Supply - Investopedia
- 1 day ago - HIMS Stock Declines Amid FDA Ruling on Semaglutide - GuruFocus